We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Molecular Techniques Compared for Diagnosis of Rickettsioses

By LabMedica International staff writers
Posted on 19 Mar 2012
The diagnosis and isolation of Rickettsia species from skin biopsies may be replaced by a real time polymerase chain reaction (rt-PCR). More...


Diagnosis of Rickettsia infection would benefit by use of the more rapid and sensitive method of quantitative rt-PCR than the time-intensive and less sensitive method of culturing Rickettsia species from skin biopsies.

Scientists at the University of the Mediterranean (Marseille, France) analyzed punch biopsies or scalpel incisions of eschars collected from patients with suspected rickettsial infections between January 2007 and January 2010. Patients were classified as definitely having rickettsiosis if there was direct evidence of infection with a Rickettsia species using culture or molecular assays or if serology was positive. Rickettsial diseases are zoonoses caused by obligate intracellular bacteria.

Total genomic DNA was extracted from samples using a QIAamp tissue kit (Qiagen, Hilden, Germany). Samples were screened for the presence of Rickettsia species using a previously developed rt-PCR assay targeting a 109 base pairs (bp) fragment of a hypothetical protein. Quantification of Rickettsia species were performed using serial ten-fold dilutions of R. africae, R. slovaca, R. raoultii, and R. helvetica. Bacteria were detected by indirect immunofluorescence using human serum and antiserum. All sera were tested by immunofluorescence (IF) for spotted fever group (SFG) rickettsial antigens. Samples were cultured in human embryonic lung (HEL) fibroblasts using the centrifugation-shell vial technique.

Rickettsia species infection was diagnosed in 47/145 (32%) skin biopsies from patients with suspected rickettsiosis. By rt-PCR a positive result was obtained for 41 skin biopsies (28.2%). Rickettsia africae was the most common detected species, followed by R. conorii conorii, R. slovaca, R. sibirica mongolitimonae, and R. raoultii. Comparison of culture and rt-PCR to serology was done for the 26 patients with suspected rickettsiosis with a skin biopsy that also had an acute serum and a convalescent-phase serum sample. The rt-PCR sensitivity was 82% as compared to serology whereas culture sensitivity was 29.4% as compared to serology.

The author concluded that for the diagnosis of Rickettsia infection the use of molecular and culture diagnostic tools, decreases the time of diagnosis and increases the sensitivity. However, a negative result using molecular assays does not exclude the diagnosis of Rickettsia infection. To increase the sensitivity of culture, skin biopsies should be sampled before treatment early in the course of the disease and should be inoculated as soon as possible. The study was published on March 6, 2012, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University of the Mediterranean
Qiagen




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.